Skip to main content
Premium Trial:

Request an Annual Quote

GPC Biotech Licenses IP from Ariad

NEW YORK, Feb. 4 - GPC Biotech of Martinsried, Germanyhas non-exclusively licensed patents from Ariad pharmaceuticals in the area of cell-signaling regulation technology, the company said today.

 

This additional IP allows the company to add this technology to its LeadCode drug discovery platform, a modified yeast two-hybrid proteomics methodology that screens for interactions between a small molecule and the full complement of human proteins.

 

This new IP licensing agreement follows on the heels of GPC's collaboration with Eli Lilly Jan. 31 to use LeadCode for mechanism of action studies on a class of metabolic disease lead compounds.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.